Is Impel Pharmaceuticals Inc. (IMPL) a Buy, Sell, or Hold?
NASDAQ : IMPL
Impel Pharmaceuticals Inc. — Insider Trades
$0.04 USD
-$0.01 (-27.27%)
- Volume
- 720.03K
- Average Volume
- 1.05M
- Market Capitalization
- $956K
- P/E Ratio
- -0.01
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $4.20
- Year Low
- $0.02
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.60
Insider Activity Summary (Last 12 Months)
Insiders Buying
16
Insiders Selling
15
Amount of Insider Selling
$634.2K
IMPL Insider Buying/Selling by Quarter
IMPL Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Smith Brandon D | officer | 2023-12-18 | 0 | 2023-12-26 | |
| Vivo Capital VIII, LLC | 10 percent owner | 2023-12-15 | S-Sale | 0.29 | 2023-12-19 |
| Vivo Capital VIII, LLC | 10 percent owner | 2023-12-18 | S-Sale | 0.11 | 2023-12-19 |
| Vivo Capital VIII, LLC | 10 percent owner | 2023-12-19 | S-Sale | 0.08 | 2023-12-19 |
| Vivo Capital VIII, LLC | 10 percent owner | 2023-12-15 | S-Sale | 0.29 | 2023-12-19 |
| Vivo Capital VIII, LLC | 10 percent owner | 2023-12-18 | S-Sale | 0.11 | 2023-12-19 |
| Vivo Capital VIII, LLC | 10 percent owner | 2023-12-19 | S-Sale | 0.08 | 2023-12-19 |
| BROOKFIELD Corp /ON/ | 10 percent owner | 2023-11-30 | J-Other | 0.01 | 2023-12-04 |
| Oaktree GCP Fund Delaware Holdings, L.P. | 10 percent owner | 2023-11-30 | J-Other | 0.01 | 2023-12-04 |
| Oaktree-TCDRS Strategic Credit, LLC | 10 percent owner | 2023-11-30 | J-Other | 0.01 | 2023-12-04 |
| BROOKFIELD Corp /ON/ | 10 percent owner | 2023-11-10 | 0.01 | 2023-11-20 | |
| Oaktree GCP Fund Delaware Holdings, L.P. | 10 percent owner | 2023-11-10 | 0.01 | 2023-11-20 | |
| Oaktree-TCDRS Strategic Credit, LLC | 10 percent owner | 2023-11-10 | 0.01 | 2023-11-20 | |
| Cline Darren S | director | 2023-06-16 | A-Award | 1.34 | 2023-06-20 |
| Wilfong Diane E. | director | 2023-06-16 | A-Award | 1.34 | 2023-06-20 |
| SHAH MAHENDRA | director | 2023-06-16 | A-Award | 1.34 | 2023-06-20 |
| NELSON TIMOTHY S | director | 2023-06-16 | A-Award | 1.34 | 2023-06-20 |
| Allison David D. | director | 2023-06-16 | A-Award | 1.34 | 2023-06-20 |
| Kalb Michael Wayne | officer: CFO | 2023-05-10 | A-Award | 2.43 | 2023-05-12 |
| Kalb Michael Wayne | officer: CFO | 2023-05-10 | A-Award | 0 | 2023-05-12 |
| Kalb Michael Wayne | officer: CFO | 2023-05-10 | 0 | 2023-05-12 | |
| Cline Darren S | director | 2023-04-12 | A-Award | 1.42 | 2023-04-14 |
| Cline Darren S | director | 2023-04-12 | 0 | 2023-04-13 | |
| Amin Rajiv | officer: VP, Controller & Interim CFO | 2023-03-10 | 0 | 2023-03-10 | |
| Amin Rajiv | officer: VP, Controller & Interim CFO | 2023-03-10 | 10.02 | 2023-03-10 | |
| Amin Rajiv | officer: VP, Controller & Interim CFO | 2023-03-10 | 12.16 | 2023-03-10 | |
| Amin Rajiv | officer: VP, Controller & Interim CFO | 2023-03-10 | 9.85 | 2023-03-10 | |
| Amin Rajiv | officer: VP, Controller & Interim CFO | 2023-03-10 | 2.29 | 2023-03-10 | |
| Paolillo Leonard | officer: Chief Commercial Officer | 2023-02-14 | A-Award | 2.29 | 2023-02-16 |
| Hoekman John | officer: Chief Scientific Officer | 2023-02-14 | A-Award | 2.29 | 2023-02-16 |
| Leaman John Harold | officer: Chief Fin. & Business Officer | 2023-02-14 | A-Award | 2.29 | 2023-02-16 |
| ADAMS ADRIAN | director, officer: COB, CEO and President | 2023-02-14 | A-Award | 2.29 | 2023-02-16 |
| Leaman John Harold | officer: Chief Fin. & Business Officer | 2022-12-31 | M-Exempt | 0 | 2023-01-04 |
| Leaman John Harold | officer: Chief Fin. & Business Officer | 2022-12-31 | F-InKind | 3.75 | 2023-01-04 |
| Leaman John Harold | officer: Chief Fin. & Business Officer | 2022-12-31 | M-Exempt | 0 | 2023-01-04 |
| Wilfong Diane E. | director: | 2022-06-16 | A-Award | 0 | 2022-06-17 |
| Wilfong Diane E. | director | 2022-06-16 | A-Award | 8.65 | 2022-06-17 |
| SHAH MAHENDRA | director | 2022-06-16 | A-Award | 8.65 | 2022-06-17 |
| SHAH MAHENDRA | director: | 2022-06-16 | A-Award | 0 | 2022-06-17 |
| NELSON TIMOTHY S | director: | 2022-06-16 | A-Award | 0 | 2022-06-17 |
| PARKER H STEWART | director | 2022-06-16 | A-Award | 8.65 | 2022-06-17 |
| PARKER H STEWART | director: | 2022-06-16 | A-Award | 0 | 2022-06-17 |
| Allison David D. | director: | 2022-06-16 | A-Award | 0 | 2022-06-17 |
| SHREWSBURY STEPHEN B | officer: Chief Medical Officer | 2022-03-29 | M-Exempt | 1.97 | 2022-03-30 |
| SHREWSBURY STEPHEN B | officer: Chief Medical Officer | 2022-01-26 | A-Award | 9.85 | 2022-01-28 |
| Paolillo Leonard | officer: Chief Commercial Officer | 2022-01-26 | A-Award | 9.85 | 2022-01-28 |
| Leaman John Harold | officer: Chief Fin. & Business Officer | 2022-01-26 | A-Award | 9.85 | 2022-01-28 |
| Hoekman John | officer: Chief Scientific Officer | 2022-01-26 | A-Award | 9.85 | 2022-01-28 |
| ADAMS ADRIAN | director, officer: COB, CEO and President | 2022-01-26 | A-Award | 9.85 | 2022-01-28 |
| Hoekman John | officer: Chief Scientific Officer | 2021-12-22 | M-Exempt | 1.64 | 2021-12-23 |
| Hoekman John | officer: Chief Scientific Officer | 2021-12-22 | M-Exempt | 1.64 | 2021-12-23 |
| NELSON TIMOTHY S | director | 2021-11-19 | P-Purchase | 10.7554 | 2021-11-22 |
| Leaman John Harold | officer: Chief Fin. & Business Officer | 2021-10-19 | A-Award | 0 | 2021-10-21 |
| SHREWSBURY STEPHEN B | officer: Chief Medical Officer | 2021-09-21 | M-Exempt | 2.95 | 2021-09-22 |
| SHREWSBURY STEPHEN B | officer: Chief Medical Officer | 2021-09-21 | M-Exempt | 2.95 | 2021-09-22 |
| SHREWSBURY STEPHEN B | officer: Chief Medical Officer | 2021-09-21 | M-Exempt | 2.46 | 2021-09-22 |
| SHREWSBURY STEPHEN B | officer: Chief Medical Officer | 2021-09-21 | M-Exempt | 1.97 | 2021-09-22 |
| SHREWSBURY STEPHEN B | officer: Chief Medical Officer | 2021-09-21 | M-Exempt | 2.46 | 2021-09-22 |
| SHREWSBURY STEPHEN B | officer: Chief Medical Officer | 2021-09-21 | M-Exempt | 1.97 | 2021-09-22 |
| ADAMS ADRIAN | director, officer: COB, CEO and President | 2021-08-18 | P-Purchase | 15.8865 | 2021-08-19 |
| ADAMS ADRIAN | director, officer: COB, CEO and President | 2021-08-18 | P-Purchase | 14.9073 | 2021-08-19 |
| ADAMS ADRIAN | director, officer: COB, CEO and President | 2021-08-18 | P-Purchase | 13.8061 | 2021-08-19 |
| SHREWSBURY STEPHEN B | officer: Chief Medical Officer | 2021-07-20 | A-Award | 12.16 | 2021-07-26 |
| Paolillo Leonard | officer: Chief Commercial Officer | 2021-07-20 | A-Award | 12.16 | 2021-07-26 |
| Leaman John Harold | officer: Chief Financial Officer | 2021-07-20 | A-Award | 12.16 | 2021-07-26 |
| Hoekman John | officer: Chief Scientific Officer | 2021-07-20 | A-Award | 12.16 | 2021-07-26 |
| ADAMS ADRIAN | director, officer: COB, CEO and President | 2021-07-20 | A-Award | 12.16 | 2021-07-26 |
| Wilfong Diane E. | director | 2021-07-11 | A-Award | 9.96 | 2021-07-13 |
| SHAH MAHENDRA | director | 2021-07-11 | A-Award | 9.96 | 2021-07-13 |
| PARKER H STEWART | director | 2021-07-11 | A-Award | 9.96 | 2021-07-13 |
| NELSON TIMOTHY S | director | 2021-07-11 | A-Award | 9.96 | 2021-07-13 |
| Allison David D. | director | 2021-07-11 | A-Award | 9.96 | 2021-07-13 |
| PARKER H STEWART | director: | 2021-04-27 | 0 | 2021-06-22 | |
| PARKER H STEWART | director | 2021-04-22 | 0 | 2021-06-22 | |
| PARKER H STEWART | director | 2021-04-22 | 0 | 2021-06-22 | |
| Vivo Capital VIII, LLC | 10 percent owner | 2021-04-27 | P-Purchase | 15 | 2021-04-29 |
| Vivo Capital VIII, LLC | 10 percent owner | 2021-04-27 | C-Conversion | 13.5 | 2021-04-29 |
| Vivo Capital VIII, LLC | 10 percent owner | 2021-04-27 | C-Conversion | 0 | 2021-04-29 |
| Vivo Capital VIII, LLC | 10 percent owner | 2021-04-27 | C-Conversion | 0 | 2021-04-29 |
| Vivo Capital VIII, LLC | 10 percent owner | 2021-04-27 | C-Conversion | 0 | 2021-04-29 |
| Vivo Capital VIII, LLC | 10 percent owner | 2021-04-27 | C-Conversion | 0 | 2021-04-29 |
| Vivo Capital VIII, LLC | 10 percent owner | 2021-04-27 | P-Purchase | 15 | 2021-04-29 |
| Vivo Capital VIII, LLC | 10 percent owner | 2021-04-27 | C-Conversion | 13.5 | 2021-04-29 |
| Vivo Capital VIII, LLC | 10 percent owner | 2021-04-27 | C-Conversion | 0 | 2021-04-29 |
| Vivo Capital VIII, LLC | 10 percent owner | 2021-04-27 | C-Conversion | 0 | 2021-04-29 |
| Vivo Capital VIII, LLC | 10 percent owner | 2021-04-27 | C-Conversion | 0 | 2021-04-29 |
| Vivo Capital VIII, LLC | 10 percent owner | 2021-04-27 | C-Conversion | 0 | 2021-04-29 |
| Vivo Capital VIII, LLC | 10 percent owner | 2021-04-27 | C-Conversion | 0 | 2021-04-29 |
| Vivo Capital VIII, LLC | 10 percent owner | 2021-04-27 | C-Conversion | 0 | 2021-04-29 |
| Vivo Capital VIII, LLC | 10 percent owner | 2021-04-27 | C-Conversion | 13.5 | 2021-04-29 |
| Vivo Capital VIII, LLC | 10 percent owner | 2021-04-27 | C-Conversion | 0 | 2021-04-29 |
| Vivo Capital VIII, LLC | 10 percent owner | 2021-04-27 | C-Conversion | 0 | 2021-04-29 |
| 5AM Ventures V, L.P. | 10 percent owner | 2021-04-27 | C-Conversion | 13.5 | 2021-04-29 |
| 5AM Ventures V, L.P. | 10 percent owner | 2021-04-27 | C-Conversion | 0 | 2021-04-29 |
| 5AM Ventures V, L.P. | 10 percent owner | 2021-04-27 | C-Conversion | 0 | 2021-04-29 |
| 5AM Ventures V, L.P. | 10 percent owner | 2021-04-27 | C-Conversion | 0 | 2021-04-29 |
| 5AM Ventures V, L.P. | 10 percent owner | 2021-04-27 | C-Conversion | 0 | 2021-04-29 |
| 5AM Ventures V, L.P. | 10 percent owner | 2021-04-27 | P-Purchase | 15 | 2021-04-29 |
| 5AM Ventures V, L.P. | 10 percent owner | 2021-04-27 | C-Conversion | 0 | 2021-04-29 |
| 5AM Ventures V, L.P. | 10 percent owner | 2021-04-27 | C-Conversion | 0 | 2021-04-29 |